Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Opium 10mg/mL tincture (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum [cns narcotic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum 10mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum 20mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum BP 15.4mg/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum BP 7.7mg/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mixed opium alkaloids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing papaveretum and scopolamine hydrobromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Opium alkaloid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing papaveretum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paregoric 2mg/5mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Belladonna alkaloid 16.2 mg and opium 30 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing opium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opium preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|